Measles-containing-vaccine second-dose (MCV2) … MCV2, WUENIC in Madagascar
Madagascar: Measles-containing-vaccine second-dose (MCV2) immunization coverage was 41.0% in 2025. ◆ Volatile
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Madagascar, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Madagascar recorded 41.0% for measles-containing-vaccine second-dose (mcv2) immunization coverage in 2025.
Compared with earlier readings it is down 10.9% on the previous year and up 192.9% over five years.
Over the whole period, measles-containing-vaccine second-dose (mcv2) immunization coverage in Madagascar peaked at 47.0% in 2023 and was at its lowest, 0.0%, in 2000.
That places Madagascar 183rd out of 194 countries with data for 2025, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Madagascar, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 0.0% | — |
| 2007 | 0.0% | — |
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 0.0% | — |
| 2014 | 0.0% | — |
| 2015 | 0.0% | — |
| 2016 | 0.0% | — |
| 2017 | 0.0% | — |
| 2018 | 0.0% | — |
| 2019 | 0.0% | — |
| 2020 | 14.0% | — |
| 2021 | 24.0% | +71.4% |
| 2022 | 32.0% | +33.3% |
| 2023 | 47.0% | +46.9% |
| 2024 | 46.0% | -2.1% |
| 2025 | 41.0% | -10.9% |
Madagascar compared with similar countries
- Madagascar's 41.0% is below the median for low income countries, which is 60.0%, 68% of the median. (25 countries reporting)
- Madagascar's 41.0% is below the median for Sub-Saharan Africa, which is 66.0%, 62% of the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 10 |
| 2010s | 0.0% | 0.0% | 0.0% | 10 |
| 2020s | 34.0% | 14.0% | 47.0% | 6 |
Countries ranked near Madagascar
- 181 Mozambique 44.0% compare
- 182 Afghanistan 42.0% compare
- 184 Vanuatu 40.0% compare
- 185 Yemen 38.0% compare
- 185 Venezuela 38.0% compare
More health data for Madagascar
- Un projection of annual infant deaths, annual growth rate -1.87 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.4912 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 920.6 deaths per 1,000 people (2090)
- Number of infants who die before age 1 14,569 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 63 (2025)
- Population ages 00-04, female, annual growth rate 1.32 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.071 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.3 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is measles-containing-vaccine second-dose (mcv2) immunization coverage in Madagascar?
- Measles-containing-vaccine second-dose (mcv2) immunization coverage in Madagascar was 41.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Madagascar?
- The highest recorded value was 47.0% in 2023.
- What is the lowest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Madagascar?
- The lowest recorded value was 0.0% in 2000.
- How does Madagascar rank for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Madagascar ranks 183rd out of 194 countries with data for 2025.
- Where does this Madagascar data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).